Skip to main content
Signal8

Phreesia, Inc. (PHR)

Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.

Sector: Services-Business Services, NEC

Industry: Medical - Healthcare Information Services

Phreesia, Inc. logo

Phreesia, Inc.

NYSE:PHRHealthcare
-0.16%$12.70
AH Close$12.70+0.00%vs close
Mkt Cap$788.3M
Float49.93M
O/S62.07M
Inst Own94.0%
SI6.0%
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$788.30M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership93.97%

based on 62.07M shares outstanding

SectorHealthcare
IndustryMedical - Healthcare Information Services
ExchangeNYSE
CountryUSUS
IPO DateJul 18, 2019
Shares Outstanding62.07M
Float49.93M
Company Overview

Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada.

Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients.

Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.

Leadership

Allison Hoffman

General Counsel & Secretary

Amy Beth VanDuyn

Senior Vice President of Human Resources

Balaji Gandhi

Chief Financial Officer

Chaim Indig

Co-Founder, Chief Executive Officer & Director

Employees

2K+

Country

US

Sector

Healthcare

Website

phreesia.com

Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
No price targets available
Ratings Distribution
BUY
18
HOLD
7
SELL
0
TOTAL25
Insider Trading
InsiderTypeShares
Hoffman Allison C profile photoHoffman Allison CSale6.7K
Roberts Evan profile photoRoberts EvanAutomatic Sell4.5K
Linetsky David profile photoLinetsky DavidAutomatic Sell4.5K
Linetsky David profile photoLinetsky DavidAutomatic Sell319
Hoffman Allison C profile photoHoffman Allison CAutomatic Sell7.4K
VanDuyn Amy Beth profile photoVanDuyn Amy BethAutomatic Sell2.9K
Shareholders
94.0%
Institutional
(225)
7.8%
Insiderⓘ
(15)
0.0%
5%+ Owners
(0)
-
Unattributed (incl. retail)ⓘ
Institutional94.0%
Insider7.8%
Sources: 13F, Form 4, 13D/13GO/S: 62.1M · as of 27 Aug 2026 · SEC cover page
Insiders & Institutional Holders
52-Week Range
$7.77$30.43
$12.70(22nd percentile)
Volume
Average Daily Volume662.24K
696.51K today vs 662.24K avg(+5%)

30d Avg

662.24K

60d Avg

708.89K

90d Avg

744.77K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...